期刊文献+

CD137分子通过微小RNA-145a-5p调控载脂蛋白E-/-小鼠活化T细胞核因子c1表达 被引量:2

CD137 signaling regulates the expression of nuclear factor of activated T cells c1 through miR-145a-5p in ApoE-/-mice
原文传递
导出
摘要 目的 探讨CD137分子信号通路是否通过微小RNA-145a-5p (miR-145a-5p)调控活化T细胞核因子c1(NFATc1)表达.方法 选取18只载脂蛋白(Apo)E-/-小鼠,8周龄,颈动脉硅胶圈植入建立模型后,根据随机区组法分为对照组、CD137刺激组和CD137抑制组,每组6只;采用荧光定量PCR(qRT-PCR)检测小鼠颈动脉斑块以及平滑肌细胞中miR-145a-5p含量;免疫荧光检测斑块中NFATc1分布,qRT-PCR、Western blot方法检测小鼠体内、外NFATc1表达.用脂质体转染miR-145a-5p的拟似物和抑制物进入血管平滑肌细胞(VSMC);通过分子克隆技术构建NFATc1真核表达载体p3xFLAG-NFATc1、p3xFLAG-NFATc 1-3' UTR.构建双荧光素酶报告载体psicheck2-NFATc1,并通过同源重组法构建psicheck2-NFATc1的突变载体psicheck2-NFATc1-Mut转染细胞后分为正常组和突变组.结果 CD137刺激组ApoE-/-小鼠斑块及VSMC中miR-145a-5p水平明显低于对照组(分别为0.21 ±0.06比1.00±0.00,P<0.05;0.22±0.07比0.50±0.12,P<0.05),斑块内NFATc1表达高于对照组(P <0.05);CD137抑制组ApoE-/-小鼠斑块及VSMC中miR-145a-5p水平低于CD137刺激组(分别为0.74±0.17比0.21 ±0.06,P<0.05;0.78 ±0.12比0.22 ±0.07,P<0.05),而斑块内NFATc1表达高于CD137刺激组(P<0.05).miR-145a-5p的拟似物处理组中NFATc1表达低于对照组,而抑制物处理组中NFATc1表达高于对照组(P<0.05);p3xFLAG-NFATc1-3' UTR过表达组中外源性NFATc1表达低于对照组(P<0.05);双荧光素酶实验中,正常组中拟似物处理组荧光水平明显低于对照组(0.56±0.08比1.00 ±0.00,P<0.05),突变组中荧光水平与对照组比较差异无统计学意义.结论 CD137分子能够通过miR-145a-5p调控NFATc1的表达. Objective To investigate if miR-145a-5p participates the modulation process of CD137 signaling on the expression of nuclear factor of activated T cells c1 (NFATc1) in ApoE-/-mice.Methods Atherosclerotic plaque model was produced by perivascular carotid collar placement in ApoE-/-mice.After surgery, the mice were randomly divided into the following groups: CD137 activated group (CD137 group, n =6) ,CD137 inhibited group (anti-CD137 group, n =6) and control group(n =6).The mRNA expression of miR-145a-Sp in plaque and cells was measured by real-time quantitative PCR (RT-PCR).Immunofluorescence was used to observe the distribution of NFATc1 in plaque and the expression of NFATc1 at mRNA and protein levels were detected by qRT-PCR, Western blot, respectively.The mouse vascular smooth muscle cells (VSMCs) were isolated and transfected with miR-145a-5p mimics or inhibitors by Lipofectamine.The eukaryotic expression vector and luciferase vector including p3xFLAG-NFATc1, p3xFLAG-NFATc1-3'UTR,psicheck2-NFATc1, psicheck2-NFATc1-Mut were constructed through molecular cloning and homologous recombination techniques, 293T cells were transfected with the miR-145a-5p mimics or inhibitors and the protein level and fluorescence intensity were then measured, respectively.Results In vivo or in vitro, the level of miR-145a-5p was significantly decreased (0.21 ± 0.06 vs.1.00 ± 0.00, P 〈0.05,0.22 ± 0.07 vs.0.50 ± 0.12, P 〈 0.05) while the opposite effects were observed in anti-CD137 group.NFATc1 expression was decreased or increased in VSMCs transfected with miR-145a-5p mimics or inhibitors, respectively (all P 〈 0.05).miR-145a-5p mimics decreased the expression of p3xFLAG-NFATc1-3'UTR and the fluorescence intensity (0.56 ± 0.08 vs.1.00 ± 0.00, P 〈 0.05).Conclusion CD137 signaling participates the regulation process on the expression of NFATc1 through miR-145a-5p in ApoE-/-mice.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2015年第10期887-893,共7页 Chinese Journal of Cardiology
基金 国家自然科学基金(81170279,81370409) 江苏省科教兴卫工程(LJ201116) 镇江市社会发展及心血管病重点实验室项目(SH2013023,SS2012002) 六大人才高峰(WS074)
关键词 动脉粥样硬化 微小RNAS 抗原 CDl37 NFATC转录因子类 Atherosclerosis MicroRNAs Antigens, CD137 NFATC transcription factors
  • 相关文献

参考文献4

二级参考文献35

  • 1Yan JC, Wu ZG, Huang Z, et al. Clinical implications of increased expression of CD40L in patients with acute coronary syndromes[J]. Chin Med J (Engl) ,2002,115(4) :491-493.
  • 2Sehonbeck U, Sukhova GK, Shimizu K, et al. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice[J]. Proc Natl Acad Sci U SA,2000,97(13) :7458-7463.
  • 3Ross R. Atherosclerosis-an inflammatory disease[J]. N Engl J Med, 1999,340(2) :115-126.
  • 4Mach F, Schonbeck U, Bonnefoy JY, et al. Activation of mono- cyte/macrophage functions related to acute atheroma complica- tion by ligation of CIM0 :induction of collagenase, stromelysin, and tissue factor[J]. Circulation, 1997,96 (2) : 396-399.
  • 5Lutgens E, Daemen MJ. CD40-CD40L interactions in athero- sclerosis[J]. Trends Cardiovase ivied, 2002,12(1) : 27-32.
  • 6Xu Q. Mouse models of arteriosclerosis:from arterial injuries to vascular grafts[J]. Am J Pathol,2004,165(1): 1-10.
  • 7Zhang SH, Reddick RL, Piedrahita JA, et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apoli- poprotein E[J]. Science, 1992,258(5081) : 468-471.
  • 8Van Put DJ ,Van Osselaer N,De Meyer GR,et al. Role of poly- morphonuclear leukocytes in collar-induced intimal thickening in the rabbit carotid artery[J]. Arterioscler Thromb Vasc Biol, 1999,18(6) : 915-921.
  • 9Binder CJ, Chang MK, Shaw PX, et al. Innate and ac- quired immunity in atherogenesis [ J]. Nat Med, 2002, 8 (11) :1218 -1226.
  • 10Steinberg D. Atherogenesis in perspective: hypercholester- olemia and inflammation as partners in crime [ J ]. Nat Med, 2002, 8(11):1211 -1217.

共引文献11

同被引文献40

  • 1Ammirati E, Moroni F, Magnoni M, et al. The role of T and B ceils in human atherosclerosis and atherothrombosis[ J. Clin Exp Immunol, 2015,179(2) :173-187.
  • 2Park KH, Park WJ. Endothelial Dysfunction : Clinical Implications in Cardiovascular Disease and Therapeutic Approaches[ J ]. J Korean Med Sci, 2015,30 (9) : 1213-1225.
  • 3Bekkering S, Joosten LA, van der Meer JW, et al. The epigenetic memory of monocytes and macrophages as a novel drug target in atherosclerosis[ J]. Clin Ther, 2015,37(4) :914-923.
  • 4Hansson GK. Atherosclerosis - an immune disease: The Anitschkov Lecture 2007 [ J ]. Atherosclerosis, 2009,202 ( 1 ) : 2- 10.
  • 5Tselios K, Sarantopoulos A, Gkougkourelas I, et al. T regulatory cells: a promising new target in atherosclerosis [ J ]. Crit Rev Immunol, 2014,34 (5) :389-397.
  • 6Lin J, Li M, Wang Z, et al. The role of CD4 + CD25+ regulatory T cells in macrophage-derived foam-cell formation [ J ]. J Lipid Res, 2010,51(5) :1208-1217.
  • 7Moos MP, John N, Grabner R, et al. The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice [ J ]. Arterioscler Thromb Vasc Biol, 2005,25 ( 11 ) : 2386-2391.
  • 8Jongstra-Bilen J, Haidari M, Zhu SN, et al. Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis [ J]. J Exp Med, 2006,203 (9) : 2073-2083.
  • 9Vinay DS, Kwon BS. 4-1BB ( CD137 ), an inducible costimulatory receptor, as a specific target for cancer therapy[ J]. BMB Rep, 2014,47(3) :122-129.
  • 10Cheuk AT, Mufti GJ, Guinn BA. Role of4-1BB:4-1BB ligand in cancer immunotherapy [J ]. Cancer Gene Ther, 2004, 11 ( 3 ) : 215-226.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部